The estimated Net Worth of Laura L. Johnson is at least $560 dollars as of 30 May 2018. Laura Johnson owns over 500 units of Odonate Therapeutics Inc stock worth over $560 and over the last 11 years Laura sold ODT stock worth over $0.
Laura has made over 2 trades of the Odonate Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Laura exercised 500 units of ODT stock worth $3,000 on 30 May 2018.
The largest trade Laura's ever made was exercising 10,000 units of Odonate Therapeutics Inc stock on 29 December 2017 worth over $89,000. On average, Laura trades about 583 units every 8 days since 2013. As of 30 May 2018 Laura still owns at least 500 units of Odonate Therapeutics Inc stock.
You can see the complete history of Laura Johnson stock trades at the bottom of the page.
Laura's mailing address filed with the SEC is 6, 10182 Telesis Ct, San Diego, CA 92121, USA.
Over the last 7 years, insiders at Odonate Therapeutics Inc have traded over $20,636,060 worth of Odonate Therapeutics Inc stock and bought 10,839,138 units worth $199,522,296 . The most active insiders traders include Capital, Llc Eco R1, Aaron I. Davis, eKevin Ctang Capital Partner.... On average, Odonate Therapeutics Inc executives and independent directors trade stock every 26 days with the average trade being worth of $444,503. The most recent stock trade was executed by Capital, Llc Eco R1 on 1 December 2021, trading 5,887,610 units of ODT stock currently worth $9,714,557.
Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Odonate’s initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are widely used in the treatment of cancer. Odonate’s goal for tesetaxel is to develop an effective chemotherapy choice for patients that provides quality-of-life advantages over current alternatives.
Odonate Therapeutics Inc executives and other stock owners filed with the SEC include: